BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10578289)

  • 1. A short-course therapy with FTY720 prolongs allograft survival after canine kidney transplantation.
    Omura T; Suzuki T; Shimamura T; Jin MB; Yokota R; Fukai M; Iida J; Taniguchi M; Magata S; Horiuchi H; Yamashita K; Nomura M; Kishida A; Matsushita M; Furukawa H; Todo S
    Transplant Proc; 1999 Nov; 31(7):2783-4. PubMed ID: 10578289
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose-dependent study of a novel immunosuppressant, FTY720, with the canine renal allograft transplantation model.
    Suzuki T; Shimamura T; Jin MB; Yokota R; Fukai M; Iida J; Taniguchi M; Magata S; Horiuchi H; Yamashita K; Nomura M; Omura T; Kishida A; Furukawa H; Todo S
    Transplant Proc; 1999; 31(1-2):1208-9. PubMed ID: 10083540
    [No Abstract]   [Full Text] [Related]  

  • 3. An effect of FTY720 on acute rejection in canine renal transplantation.
    Yuzawa K; Otsuka M; Taniguchi H; Takada Y; Sakurayama N; Jinzenji Y; Suzuki S; Fukao K
    Transplant Proc; 1998 Jun; 30(4):1046. PubMed ID: 9636422
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppressive action of FTY720 for renal allograft a rat model.
    Kunikata S; Nagano T; Nishioka T; Akiyama T; Kurita T
    Transplant Proc; 1999; 31(1-2):1157-9. PubMed ID: 10083517
    [No Abstract]   [Full Text] [Related]  

  • 5. FTY720: mechanisms of action and its effect on organ transplantation (review).
    Suzuki S
    Transplant Proc; 1999 Nov; 31(7):2779-82. PubMed ID: 10578288
    [No Abstract]   [Full Text] [Related]  

  • 6. FTY720, a novel immunosuppressant, induces sequestration of circulating lymphocytes by acceleration of lymphocyte homing.
    Chiba K; Yanagawa Y; Kataoka H; Kawaguchi T; Ohtsuki M; Hoshino Y
    Transplant Proc; 1999; 31(1-2):1230-3. PubMed ID: 10083549
    [No Abstract]   [Full Text] [Related]  

  • 7. Rescue effect of FTY720 on acute renal rejection in dogs.
    Yuzawa K; Otsuka M; Taniguchi H; Takada Y; Sakurayama N; Jinzenji Y; Suzuki S; Fukao K
    Transplant Proc; 1999; 31(1-2):872. PubMed ID: 10083381
    [No Abstract]   [Full Text] [Related]  

  • 8. FTY720, a novel immunosuppressant possessing unique mechanisms. III. Synergistic prolongation of canine renal allograft survival in combination with cyclosporine A.
    Kawaguchi T; Hoshino Y; Rahman F; Amano Y; Higashi H; Kataoka H; Ohtsuki M; Teshima K; Chiba K; Kakefuda T; Suzuki S
    Transplant Proc; 1996 Apr; 28(2):1062-3. PubMed ID: 8623227
    [No Abstract]   [Full Text] [Related]  

  • 9. An immunosuppressive regimen using FTY720 combined with cyclosporin in canine kidney transplantation.
    Suzuki S; Kakefuda T; Amemiya H; Chiba K; Hoshino Y; Kawaguchi T; Kataoka H; Rahman F
    Transpl Int; 1998; 11(2):95-101. PubMed ID: 9561675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTY-720 is efficacious in monkey kidney transplantation.
    Quesniaux V; Menninger K; Audet M; Gaschen L; Schuurman HJ
    Transplant Proc; 2001 May; 33(3):2374-5. PubMed ID: 11377564
    [No Abstract]   [Full Text] [Related]  

  • 11. FTY720, a novel immunosuppressant, shows a synergistic effect in combination with FK 506 in rat allograft models.
    Hoshino Y; Yanagawa Y; Ohtsuki M; Nakayama S; Hashimoto T; Chiba K
    Transplant Proc; 1999; 31(1-2):1224-6. PubMed ID: 10083547
    [No Abstract]   [Full Text] [Related]  

  • 12. Beneficial immunosuppressive effect of FTY720 combined with intrathymic injection of splenic cells on rat pancreaticoduodenal allograft.
    Suzuki K; Kazui T; Kawabe A; Li XK; Amemiya H; Suzuki S
    Transplant Proc; 1998 Jun; 30(4):1067-8. PubMed ID: 9636432
    [No Abstract]   [Full Text] [Related]  

  • 13. Rescuing acute rejection of rat cardiac allografts with FTY720.
    Chueh SC; Tsai CC; Chiu B; Li YC; Lai MK
    Transplant Proc; 2000 Nov; 32(7):1629-30. PubMed ID: 11119868
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of mycophenolate sodium with or without FTY720 in a DA-to-Lewis rat heart transplantation model.
    Matsumoto Y; Hof RP
    Transplant Proc; 2002 Nov; 34(7):2891-2. PubMed ID: 12431647
    [No Abstract]   [Full Text] [Related]  

  • 15. Perioperative administration of FTY720 and CTLA4IG in rat heart transplantation.
    Ohba M; Li XK; Kita Y; Tamura A; Enosawa S; Sasakuri S; Ogoshi S; Amemiya H; Suzuki S
    Transplant Proc; 2000 Nov; 32(7):2024-5. PubMed ID: 11120049
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolongation of concordant xenograft survival by a newly developed drug, FTY720.
    Fujiwara I; Nakajima H; Matsuda T; Mizuta N; Yamagishi H; Oka T
    Transplant Proc; 1999 Nov; 31(7):2831-3. PubMed ID: 10578306
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined therapy of CTLA4Ig-gene transfection with FTY720 administration in rat lung allografts.
    Kita Y; Nogimura H; Ida M; Kageyama Y; Ohi S; Ito Y; Matsushita K; Takahashi T; Suzuki K; Kazui T; Hayashi S; Li X; Suzuki S
    Transplant Proc; 2002 Aug; 34(5):1437-40. PubMed ID: 12176429
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate.
    Chiba K; Hoshino Y; Ohtsuki M; Kataoka H; Maeda Y; Matsuyuki H; Sugahara K; Kiuchi M; Hirose R; Adachi K
    Transplant Proc; 2005; 37(1):102-6. PubMed ID: 15808561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-specific blood transfusion does not enhance the effect of FTY720 in rat cardiac allotransplantation.
    Antoniou EA; Drayson M; Howie AJ; McMaster P; D'Silva M
    Transplant Proc; 1998 Jun; 30(4):1042-3. PubMed ID: 9636420
    [No Abstract]   [Full Text] [Related]  

  • 20. FTY720 compares with FK 506 as rescue therapy in rat heterotopic cardiac transplantation.
    Xu M; Pirenne J; Antoniou S; Gunson B; D'Silva M; McMaster P
    Transplant Proc; 1998 Aug; 30(5):2221-2. PubMed ID: 9723447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.